Clinical trial
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
NCT05677633
Study timeline
Study start (actual)2023-01-19Date precision: day
Registry last updated2025-11-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Disease and Parkinsonismunresolved
Interventions
SargramostimDRUG · verified · RxNorm: sargramostim
Sponsors & collaborators
University of Nebraskalead sponsor
Partner Therapeutics, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05677633 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.